Adaptimmune Investors

15 investors on Angel Roster list Adaptimmune in their portfolio. Most are private equity firms and venture capital firms, the most common stage is Seed and the largest groups are based in the United States and the United Kingdom.

Investors are matched on the company name in their portfolio, so companies that share the name Adaptimmune can appear together.

Investors listed
15
With verified email
60%
Most common stage
Seed
Top location
United States

Updated October 13, 2026 · How we compile this data

Top 15 Adaptimmune investors

The most complete profiles first. Showing 15 of 15.

  • Brett ZbarVerified

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareHospitalsWomen FoundedInvestment Management

    Portfolio: AveXis, Remix Therapeutics, Karyopharm Therapeutics, Olema Oncology and 68 more

    Verified email available

  • Dennis RyanVerified

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareHospitalsWomen FoundedLife Science

    Portfolio: AveXis, Remix Therapeutics, Karyopharm Therapeutics, Olema Oncology and 66 more

    Verified email available

  • Dorothy MargolskeeVerified

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareHospitalsWomen FoundedLife Science

    Portfolio: AveXis, Remix Therapeutics, Karyopharm Therapeutics, Olema Oncology and 66 more

    Verified email available

  • Matt TaylorVerified

    Venture Capital, Advisor, Private Equity Firm · United Kingdom

    SeedHealth CareHospitalsWomen FoundedLife Science

    Portfolio: AveXis, Remix Therapeutics, Karyopharm Therapeutics, Olema Oncology and 66 more

    Verified email available

  • Rhonda KaufmanVerified

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareHospitalsWomen FoundedLife Science

    Portfolio: AveXis, Remix Therapeutics, Karyopharm Therapeutics, Olema Oncology and 66 more

    Verified email available

  • Richard GasterVerified

    Venture Capital, Private Equity Firm, Investor · United States

    Series BHealth CareWomen FoundedLife ScienceManufacturing

    Portfolio: Attralus, Aurinia Pharmaceuticals, Labrys Biologics, Adaptimmune and 33 more

    Verified email available

  • Ali BehbahaniVerified

    Venture Capital, Private Equity Firm, Angel/Individual · United States

    Series BHealth CareE-commerceWomen FoundedEnterprise Software

    Portfolio: Adaptimmune, Monte Rosa Therapeutics, 858 Therapeutics, GOAT and 5 more

    Verified email available

  • David MottVerified

    Venture Capital, Angel/Individual, Investor · United States

    SeedPre-SeedEnterprise SoftwareBiotechnologyHealth and Hospital ServicesConsumer Internet

    Portfolio: Nightstar Therapeutics, Ardelyx, Cydan, Adaptimmune and 4 more

    Verified email available

  • David PezeshkiVerified

    Private Equity Firm · United States

    Health CareWomen FoundedLife ScienceManufacturing

    Portfolio: Attralus, Aurinia Pharmaceuticals, Labrys Biologics, Adaptimmune and 33 more

    Verified email available

  • Aaron Royston, M.D.

    Venture Capital, Private Equity Firm, Investor · United States

    Series BHealth CareWomen FoundedLife ScienceManufacturing

    Portfolio: Attralus, Aurinia Pharmaceuticals, Labrys Biologics, HistoWiz and 35 more

    Contact details available

  • Jaume Pons

    Venture Capital, Private Equity Firm, Investor · United States

    Series BHealth CareWomen FoundedLife ScienceManufacturing

    Portfolio: Attralus, Aurinia Pharmaceuticals, Labrys Biologics, Adaptimmune and 33 more

    Contact details available

  • Luke Bagaason, CFA

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareHospitalsWomen FoundedInvestment Management

    Portfolio: AveXis, Remix Therapeutics, Karyopharm Therapeutics, Olema Oncology and 66 more

    Contact details available

  • Richard Lau, CFA

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareHospitalsWomen FoundedInvestment Management

    Portfolio: AveXis, Remix Therapeutics, Karyopharm Therapeutics, Olema Oncology and 66 more

    Contact details available

  • Yvonne Yamanaka

    Venture Capital, Private Equity Firm, Investor · United States

    Series BHealth CareWomen FoundedLife ScienceManufacturing

    Portfolio: Attralus, Aurinia Pharmaceuticals, Labrys Biologics, Adaptimmune and 33 more

    Contact details available

  • Dominique Semon

    Private Equity Firm · United States

    Health CareAndroidSoftwareBiotechnology

    Portfolio: Adaptimmune, Sunesis Pharmaceuticals, Micromet, Zymeworks and 2 more

    Contact details available

By investment stage

By location

Related industries

Most-backed portfolio companies

Frequently asked questions

How many Adaptimmune investors are on Angel Roster?

Angel Roster lists 15 Adaptimmune investors. 9 of them (60%) include a verified email address.

What types of investors are they?

The most common investor types are Private Equity Firms (14), Venture Capital Firms (13) and Angel Investors (2). An investor can have more than one type, for example an angel who is also a venture partner.

Which stages do Adaptimmune investors invest in?

Among those that list a stage, the most common are Seed (8), Series B (5) and Pre-Seed (1).

Where are Adaptimmune investors based?

Most are based in the United States (14) and the United Kingdom (1).

Which companies have Adaptimmune investors backed?

The most-backed portfolio companies among them are Turning Point Therapeutics (12), ALX Oncology (12), Pharvaris (12), Ardelyx (8) and SAGE Therapeutics (7).

How do I contact Adaptimmune investors?

Create a free Angel Roster account to search and filter all 15, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.